Using advanced MRI techniques to improve breast cancer treatment.
Official title: Quantitative magnetic resonance imaging for non-invasive breast cancer therapy using physics-informed neural networks.
Funded at University of Utah · NIH-10997959 · Data updated 2026-11-12
This study is working on improving breast cancer treatment by using new MRI techniques that combine advanced technology and machine learning, so patients can get clearer images of how well their treatments are working, leading to better care and outcomes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $40,857 |
| NIH project number | 1F31CA288055-01A1 |
| Project ID | NIH-10997959 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with breast cancer who are undergoing or considering MR-guided focused ultrasound therapy.
✕Less likely to help
Patients with breast cancer who are not eligible for MR-guided focused ultrasound treatments may not benefit from this research.
What this research studies
This research aims to enhance breast cancer therapy by developing advanced magnetic resonance imaging (MRI) techniques that utilize machine learning. By integrating physics knowledge into deep learning models, the project seeks to create reliable quantitative MRI methods that can evaluate the effectiveness of MR-guided focused ultrasound treatments for breast cancer. Patients will benefit from improved imaging techniques that provide more accurate assessments of their treatment progress, ultimately leading to better outcomes. The research addresses existing challenges in MRI technology, such as the need for large datasets and variability across imaging protocols.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized breast cancer treatments through improved imaging techniques.
How similar studies have gone: Other research has shown promise in using machine learning for medical imaging, indicating that this approach could lead to significant advancements in breast cancer treatment.
Where this research is happening
-
University of Utah
Salt Lake City, United States Active
Researchers
- Principal investigator: Adams, Samuel Ian — University of Utah
- Study coordinator: Adams, Samuel Ian
Related research
Other NIH-funded projects on the same topics.
-
Understanding why DCIS becomes invasive breast cancer in Asian American and Native Hawaiian/Pacific Islander groups
A research project aims to identify biological factors and risk patterns that predict when early-stage DCIS may progress to invasive breast cancer, with a focus on AANHPI populations.
-
Imaging test to show whether non-invasive breast tumor treatment has worked
This project is creating a non-contrast MRI tool powered by AI to quickly show if focused ultrasound has destroyed a localized breast tumor for people with early-stage breast cancer.
-
A new imaging method to assess tissue health during breast cancer treatment
This study is testing a new way to check how well breast cancer treatments are working by using special MRI scans that don’t require any injections, helping doctors see if the tumor is responding to treatment and making sure patients get the best care possible.
-
Combining blood tests and MRI to predict treatment response in early breast cancer
This study is looking at how using blood tests to check for cancer DNA along with MRI scans can help doctors see how well early breast cancer patients are responding to their chemotherapy before surgery, so they can make better treatment decisions and improve outcomes for everyone involved.
-
Investigating how a specific protein contributes to the progression of breast cancer
This study is looking at a protein called cyclin E and how its changes might lead to aggressive breast cancer, with the hope that understanding these early changes can help improve early detection and treatment options for patients.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.